Evidence map›Paper›PMID 42557260›Full record

ArticleNature communications2026

Extensive binding of poorly characterized human transcription factors to genomic dark matter.

Rozita Razavi, Ali Fathi, Isaac Yellan, Alexander Brechalov, Kaitlin U Laverty, Arttu Jolma, Aldo Hernandez-Corchado, Hong Zheng, Ally W H Yang, Mihai Albu and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Rozita Razavi *Donnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.
Ali Fathi *Donnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.ORCID 0009-0007-1441-9653
Isaac Yellan *Donnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.ORCID 0000-0001-6622-1189
Alexander Brechalov *Donnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.
Kaitlin U LavertyDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.ORCID 0009-0004-4341-4665
Arttu JolmaDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.ORCID 0000-0002-2543-7490
Aldo Hernandez-CorchadoVictor P. Dahdaleh Institute of Genomic Medicine, Montréal, QC, Canada.ORCID 0000-0003-0682-3959
Hong ZhengDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.
Ally W H YangDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.
Mihai AlbuDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.
Marjan BarazandehDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.ORCID 0000-0003-3420-3669
Chun HuDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.
Ilya E VorontsovVavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.ORCID 0000-0001-8888-0804
Zain M PatelDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada.
Codebook Consortium
Ivan V KulakovskiyVavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.ORCID 0000-0002-6554-8128
Philipp BucherSwiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0003-4824-885X
Quaid MorrisSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-2760-6999
Hamed S NajafabadiVictor P. Dahdaleh Institute of Genomic Medicine, Montréal, QC, Canada.ORCID 0000-0003-2735-4231
Timothy R HughesDonnelly Centre and Department of Molecular Genetics, Toronto, ON, Canada. t.hughes@utoronto.ca.ORCID 0000-0002-8721-4719

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Tissue Repository CoreP30AR070549 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Leah Claire Kottyan · 2016 to 2026
$7.7M
Gene regulatory network modeling of disease-associated DNA methylation perturbationsR01AI173314 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Minji Byun, Emily Miraldi · 2023 to 2026
$3.1M
Post-transcriptional Regulatory NetworksR01HG013328 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI Quaid Morris · 2023 to 2026
$2.6M
Transcription Factor Genetics in LupusR01AR073228 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI KOTTYAN, LEAH CLAIRE, WAGGONER, STEPHEN N. · 2019 to 2023
$2.2M
CisBP and CisBP-RNA: web resources for protein-DNA and protein-RNA binding modelsU24HG013078 · NHGRI · CINCINNATI CHILDRENS HOSP MED CTR · PI Matthew Tyson Weirauch · 2024 to 2026
$1.6M
Measuring and describing nucleosome remodeler sequence preferencesR21HG012258 · NHGRI · UNIVERSITY OF TORONTO · PI HUGHES, TIMOTHY · 2022 to 2022
$267k
European Molecular Biology Organization (EMBO) 1139-2019Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-186136Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-191768Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-191802Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Conseil de Recherches en Sciences Naturelles et en Génie du Canada) RGPIN-2018-05962NCI NIH HHS P30 CA008748NHGRI NIH HHS R01 HG013328NHGRI NIH HHS R21 HG012258NHGRI NIH HHS U24 HG013078NIAID NIH HHS R01 AI173314NIAMS NIH HHS P30 AR070549NIAMS NIH HHS R01 AR073228NIH HHS P30CA008748Russian Science Foundation (RSF) 24-14-20031Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_197082Vetenskapsrådet (Swedish Research Council) 2016-00158
6 · The paper itself

Abstract

The functional impact of a large portion of the human genome known as "dark matter DNA", which is composed mainly of repeat sequences, remains unknown. The genome also encodes many putative and poorly characterized transcription factors. Here, we determine genomic binding locations of 166 poorly characterized human transcription factors in living cells. Nearly half of them associate strongly with known regulatory regions such as promoters and enhancers, frequently co-localizing with each other at conserved motif matches. The other half often associate with genomic dark matter, however, at largely non-overlapping (i.e., unique) sites, via intrinsic sequence recognition. Fifty-four of the latter half, which we term dark transcription factors, mainly bind within regions of closed chromatin, with each recognizing a unique set of repeat sequences. The dark transcription factors include many KZNFs, which are known to bind and silence transposable elements, and other transcription factors with apparent repressive functions. Others may be pioneer transcription factors. For example, we find that induction of TPRX1, a known regulator of zygotic preimplantation, leads to chromatin opening at many of its binding sites in the dark matter genome.

Indexed as

Genome, HumanTranscription FactorsBinding SitesChromatinHumansPromoter Regions, GeneticProtein BindingChromatinTranscription Factors

Identifiers

PMID42557260
PMCPMC13444102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.